Plasma ceramide levels are altered in low and normal birth weight men in response to short-term high-fat overfeeding

Scientific Reports
Amalie Ribel-MadsenC Brøns

Abstract

Low birth weight (LBW) individuals have an increased risk of developing insulin resistance and type 2 diabetes compared with normal birth weight (NBW) individuals. We hypothesised that LBW individuals exhibit an increased fatty acid flux into lipogenesis in non-adipose tissue with a resulting accumulation of lipotoxic lipids, including ceramides, in the blood. Therefore, we measured fasting plasma levels of 27 ceramides in 18 young, healthy, LBW men and 25 NBW controls after an isocaloric control diet and a 5-day high-fat, high-calorie diet by HPLC-HRMS. LBW men did not show elevated plasma ceramide levels after the control or high-fat, high-calorie diet. An increased fatty acid oxidation rate in these individuals during both diets may limit ceramide synthesis and thereby compensate for a likely increased fatty acid load to non-adipose tissue. Interestingly, LBW and NBW men decreased d18:0-18:1/d18:1-18:0 and d18:1-24:2/d18:2-24:1 levels and increased the d18:0-24:1a level in response to overfeeding. Plasma d18:0-24:1a and total ceramide levels were positively associated with the fasting blood glucose level and endogenous glucose production after the control diet, and the total ceramide level was in addition positively associat...Continue Reading

References

Aug 12, 1976·The New England Journal of Medicine·G P RavelliM W Susser
Oct 26, 1991·BMJ : British Medical Journal·C N HalesP D Winter
Nov 15, 2002·Trends in Endocrinology and Metabolism : TEM·Eileen L WhitemanMorris J Birnbaum
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Nov 1, 2003·Archives of Biochemistry and Biophysics·Sandy LightleMariana Nikolova-Karakashian
Feb 1, 2006·Progress in Lipid Research·Scott A Summers
Jan 12, 2007·American Journal of Epidemiology·Thomas HarderAndreas Plagemann
Jan 29, 2008·Physiology & Behavior·N A van Herpen, V B Schrauwen-Hinderling
Mar 25, 2008·The Journal of Biological Chemistry·Charmi ShahFahumiya Samad
Jul 17, 2008·The Journal of Clinical Endocrinology and Metabolism·Charlotte BrønsAllan Vaag
Aug 9, 2008·Endocrinology·Tamer CoskunAlexei Kharitonenkov
May 8, 2009·Apoptosis : an International Journal on Programmed Cell Death·Christine M KusminskiPhilipp E Scherer
Dec 10, 2009·American Journal of Physiology. Endocrinology and Metabolism·A C AlibegovicA Vaag
Sep 16, 2011·American Journal of Physiology. Endocrinology and Metabolism·Charlotte BrønsAllan Vaag
Dec 3, 2011·Progress in Lipid Research·Sabine GröschGerd Geisslinger
Jan 10, 2012·Cell Death and Differentiation·D Ferland-McColloughS E Ozanne
Apr 25, 2012·European Journal of Endocrinology·Sara G VienbergBirgitte Andersen
Aug 1, 2012·PloS One·Melissa N BarberClinton R Bruce
Apr 5, 2013·Journal of Internal Medicine·J BorénM Levin
Apr 25, 2013·Journal of Pediatric Endocrinology & Metabolism : JPEM·Ximena LopezPhilipp E Scherer
May 4, 2013·Obesity·Leonie K HeilbronnDorit Samocha-Bonet
May 15, 2013·Cell Metabolism·William L HollandPhilipp E Scherer
Jan 21, 2014·Analytical and Bioanalytical Chemistry·Andreas KlitgaardKristian Fog Nielsen
Feb 25, 2014·International Journal of Molecular Sciences·Kristina EisingerChrista Buechler
Jan 31, 2015·PloS One·Karolina Konstantynowicz-NowickaAdrian Chabowski
Sep 29, 2015·Trends in Endocrinology and Metabolism : TEM·Bhagirath Chaurasia, Scott A Summers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.